Table 2. Determination of CMB using NCDs in urine and serum samples (n = 5).
| Samples | Added (μM) | NCDs | ||
|---|---|---|---|---|
| Found (μM) | Recovery% | RSD% | ||
| Human urine | 0.0 | — | — | — |
| 5.0 | 5.08 | 101.6 | 3.67 | |
| 20.0 | 19.84 | 99.2 | 2.65 | |
| 50.0 | 52.67 | 105.3 | 1.98 | |
| Human serum | 0.0 | — | — | — |
| 5.0 | 4.87 | 97.4 | 4.11 | |
| 20.0 | 21.04 | 105.2 | 3.22 | |
| 50.0 | 49.76 | 99.5 | 2.87 | |